Scarica l'app Stockscreener
29.70
2.97%
0.8555
Pre-mercato:
29.72
0.0182
+0.06%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HLTH Giù?
Forum
Previsione
Precedente Chiudi:
$28.85
Aprire:
$28.85
Volume 24 ore:
31,904
Relative Volume:
4.13
Capitalizzazione di mercato:
$6.90M
Reddito:
$64.22M
Utile/perdita netta:
$-373.46M
Rapporto P/E:
-12.17
EPS:
-2.44
Flusso di cassa netto:
$-157.61M
1 W Prestazione:
+1.17%
1M Prestazione:
+1.75%
6M Prestazione:
+68,337%
1 anno Prestazione:
+68,337%
Intervallo 1D:
$28.85
$29.70
Intervallo di 1 settimana:
$28.69
$30.38
Portata 52W:
$24.88
$31.22
Cue Health Inc Stock (HLTH) Company Profile
Nome
Cue Health Inc
Settore
Industria
Telefono
858-412-8151
Indirizzo
4980 Carroll Canyon Road, Suite 100, San Diego
Compare HLTH vs VEEV, TEM, BTSG, TXG, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HLTH
Cue Health Inc
|
29.70 | 6.90M | 64.22M | -373.46M | -157.61M | -2.44 |
VEEV
Veeva Systems Inc
|
274.84 | 44.50B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
82.24 | 14.93B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
56.02 | 11.08B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
84.11 | 10.96B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
91.98 | 7.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Cue Health Inc Borsa (HLTH) Ultime notizie
Apple Pendant? Tim Cook, Eddy Cue Also Reportedly Throwing Weight Behind Another Mystery Device, Says Thi - Benzinga
Apple Explores Screenless Health Tracker, Wearable Product Line May Face Major Overhaul - nai500.com
Apple Is Developing a Screenless Fitness Tracker to Rival Whoop, Report Says - finance.biggo.com
AAPL Stock Hits Record Highs — Apple Reportedly Explores Screenless Health Trackers And Other Wearables Following iPhone Duo Launch - TradingView
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Cue Biopharma Shares Jump 41.6% Premarket Following Phase 2 Trial Results - Yahoo Finance
Eye Cue Mental Health Offers Couples Therapy by Video - The Daily News | Texas' Oldest Newspaper
Cue Health Inc. (HLTH) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Cue Biopharma Inc (CUE) Financials FY2025: Revenue $27.5M, Net Loss $26.6M - Stock Titan
CUE Stock Jumps Over 100% After Hours — What’s Driving The Rally? - Stocktwits
Cue Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights - Yahoo Finance
Enterprise value to revenue forward of CUE HEALTH INC – OTC:HLTHQ - tradingview.com
Price to earnings forward of CUE HEALTH INC – OTC:HLTHQ - TradingView
Price to sales forward of CUE HEALTH INC – OTC:HLTHQ - TradingView
Enterprise value to EBIT forward of CUE HEALTH INC – OTC:HLTHQ - TradingView
Enterprise value to EBITDA forward of CUE HEALTH INC – OTC:HLTHQ - TradingView
Cue Biopharma (CUE) hires James Ahlers as CFO with equity and severance package - Stock Titan
Cue Biopharma Inc (CUE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tema's AI ETF Targets Drug Discovery, Diagnostics and Robotics - Stock Titan
TUBI APPOINTS SHANNON OLIVAS AS HEAD OF COMMUNICATIONS AND PUBLICITY - Tubi
Needham reiterates Hold on Conmed stock amid sale exploration - Investing.com
Cue Biopharma names Dominic Borie as chief medical officer - Investing.com
Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development - Yahoo Finance
Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH - RTTNews
Cue Biopharma (Nasdaq: CUE) secures $50M private placement and grants over 1M RSUs - Stock Titan
Cue: The Market Is Paying $86M For A Drug It Doesn't Own (NASDAQ:CUE) - Seeking Alpha
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Biotech firm Cue Biopharma lines up $50M to push its immune disorder drugs - Stock Titan
Cue Health Inc. Actuals & Estimates (OTC:HLTHQ) - TradingView
Cue Biopharma Inc (CUE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Why Temasek’s CFO is moving into a new power role - Fortune
Will CONMED’s New CFO Shift CNMD’s Financial Playbook Or Deepen Its Existing Strategy? - Yahoo Finance
Conmed Names John Gallagher as New Chief Financial Officer - The Globe and Mail
Cue Biopharma (NASDAQ: CUE) registers 551,724 pre-funded-warrant shares for resale - Stock Titan
CONMED Appoints John E. Gallagher as New Chief Financial Officer, Effective July 2026 - Minichart
Conmed names John Gallagher as CFO effective July 15 By Investing.com - Investing.com Australia
Conmed names John Gallagher as CFO effective July 15 - Investing.com
CONMED (NYSE: CNMD) hires John Gallagher as CFO with equity-heavy pay - Stock Titan
CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer - Business Wire
Cue Biopharma Inc (CUE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cue Biopharma Inc (CUE) Institutional Confidence - TradingKey
Cue Biopharma, Inc. (CUE) Latest Stock News & Headlines - Yahoo Finance
Cue Biopharma adds two directors as four board members resign - Investing.com UK
CUE - Finviz
Apple’s Top Executive Uses a Whoop — What That Says About the Company’s $100 Billion Apple Watch Problem - Yahoo Finance
CUE Stock Price, Quote & Chart | CUE BIOPHARMA INC (NASDAQ:CUE) - ChartMill
Cue Biopharma CEO to present at Jefferies healthcare conference in NYC - Stock Titan
Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference - Yahoo Finance
Apple’s Eddy Cue to Receive Entertainment Person of the Year Honor at Cannes Lions Festival - Variety
Why Is Cue Health Inc. (HLTHQ) Stock Down Today? - Meyka
Cue Health Inc Azioni (HLTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.07%
2.68%
Capitalizzazione:
|
Volume (24 ore):